REFERENCES
B. A. Larder and D. G. Richman. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243:1731–1734 (1989).
H. D. Langtry and D. M. Campoli-Richards. Zidovudine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 37:408–450 (1989).
D. M. Campoli-Richards, E. M. Sorkin, and R. C. Heel. Inosine Pranobex: A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 32:383–424 (1986).
C. DeSimone, S. Tzantzoglou, V. Vullo, S. Catania, and V. Trinchieri. Inosine Pranobex and zidovudine metabolism. Lancet 2:977–978 (1989).
A. Pompidou, J. Lang, L. Telvi, M. Delsaux, and P. Sarin. Influence of immunomodulators on T lymphocyte differentiation in ARC patients and resistance to LAV/HTLV III infection. Comp. Immunol. Microbiol. Infect. Dis. 9:263–267 (1986).
R. F. Schinazi, D. L. Cannon, B. H. Arnold, and D. Martino-Saltzman. Combinations of isoprinosine and 3′-azido-3′-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 32:1784–1787 (1988).
J. G. Bekesi, P. H. Tsang, J. I. Wallace, and J. P. Roboz. Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS. J. Clin. Lab. Immunol. 24:155–161 (1987).
C. DeSimone, M. Ferrazzi, F. Bitonti, M. Falciano, S. Tzantzoglou, S. Delia, and F. Sorice. Pharmacokinetics of zidovudine and concomitant inosine-pranobex in AIDS patients. Immunopharmacol. Immunotoxicol. 10 (4):437–441 (1988).
M. A. Hedaya, W. F. Elmquist, and R. J. Sawchuk. Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers. Pharm. Res. 7:411–417 (1990).
A. Lopez-Anaya, J. D. Unadkat, L. A. Schumann, and A. L. Smith. Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer. J. AIDS 3:959–964 (1990).
M. Gibaldi and D. Perrier. Pharmacokinetics, 2nd ed., Marcel Dekker, New York, 1982, pp. 409–416.
P. de Miranda, S. S. Good, R. Yarchoan, R. V. Thomas, R. Blum, C. E. Myers, and S. Broder. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex. Clin. Pharmacol. Ther. 46:494–500 (1989).
M. A. Hedaya and R. J. Sawchuk. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit. J. Pharm. Sci. 78:716–722 (1989).
J.-Y. Chatton, M. Odone, K. Besseghir, and F. Rah-Ramel. Renal secretion of 3′-azido-3′-deoxythymidine by the rat. J. Pharmacol. Exp. Ther. 255:140–145 (1990).
A. Lopez-Anaya, J. D. Unadkat, L. A. Schumann, and A. L. Smith. Pharmacokinetics of zidovudine (azidothymidine). II. Development of metabolic and renal clearance pathways in the neonate. J. AIDS 3:1052–1058 (1990).
A. Lopez-Anaya, J. D. Unadkat, L. A. Schumann, and A. L. Smith. Pharmacokinetics of zidovudine (azidothymidine). III. Effect of pregnancy. J. AIDS 4:64–68 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Al-Habet, S.M.H., Nosbisch, C., Williamson, T. et al. Interaction of Zidovudine (Azidothymidine) with Isoprinosine and Probenecid in Macaca fascicularis . Pharm Res 11, 181–183 (1994). https://doi.org/10.1023/A:1018982703049
Issue Date:
DOI: https://doi.org/10.1023/A:1018982703049